Drug Profile
Icomucret
Alternative Names: 15(S)-HETE; 15(S)-hydroxyeicosatetraenoic acid; 15-HETE; AL-12959; Dry eyes therapy - Alcon; PROCALYXLatest Information Update: 15 Apr 2019
Price :
$50
*
At a glance
- Originator Alcon
- Class Antineoplastics; Eye disorder therapies; Small molecules; Vasodilators
- Mechanism of Action Mucin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Dry eyes
Most Recent Events
- 09 Apr 2019 Novartis completed the spin-off of Alcon
- 03 Jul 2007 No development reported - Phase-II for Dry eyes in European Union (unspecified route)
- 03 Jul 2007 No development reported - Phase-III for Dry eyes in USA (unspecified route)